| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |